Cardiomatics
PrivateLast Round
Seed
Aug 25, 2021
Total Funding Raised
$5.16M
Company Overview
Cardiomatics operates in Healthcare & Life Sciences and is based in Poland. Its latest recorded funding round was a Seed round in August 2021.
Cardiomatics is a health technology company that provides a cloud-based, AI-powered platform for the analysis and interpretation of electrocardiogram (ECG) data.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Healthcare Analytics, Medical Devices, Vertical SaaS
Business Model
B2B
Customer Profile
Usage-Based SaaS, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cardiomatics Comparables
Compare Cardiomatics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AccurKardia | 90% | |
| PulseAI | 87% | |
| Idoven | 87% |
For institutional investors. Book with your work email.
Cardiomatics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Aug 25, 2021 | ||||
| Grant | Aug 23, 2021 | ||||
| Pre Seed | Jul 23, 2019 | ||||
| Grant | Jul 12, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Cardiomatics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| INNOventure | Pre Seed |
| Nina Capital | Seed |
| KAYA | Seed |
| Innovation Nest | Seed |
| European Regional Development Fund | Grant |
| Nova Capital | Seed |
| National Centre for Research and Development | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 20, 2026
Software received CE/MDR certification, classifying it as medical grade.
- Aug 18, 2025
Will be present at ESC Congress 2025 in Madrid, Spain.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- attends_eventOct 29, 2026
Cardiomatics Arseus Medical Partnership attends the ESC Digital & AI Summit in Switzerland on Nov 12th–13th '26 and gives a sneak peek of its upcoming AI update.
For institutional investors. Book with your work email.
Cardiomatics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Cardiomatics's valuation, stock price, and market status.
Is Cardiomatics a public or private company?
Cardiomatics is a private company.
What is the current stock price of Cardiomatics?
Cardiomatics is a private company, so its shares have no public market price. Caplight tracks Cardiomatics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Cardiomatics worth (valuation)?
Valuation information for Cardiomatics is not publicly available.
Can I buy Cardiomatics stock?
Cardiomatics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Cardiomatics's last funding round?
Cardiomatics's most recent funding round was Seed on August 25, 2021.
Who are the main investors in Cardiomatics?
Key investors in Cardiomatics include INNOventure, KAYA.
Will Cardiomatics IPO soon?
No public IPO plans have been announced for Cardiomatics.
How can I track Cardiomatics secondary market activity?
Caplight tracks bids, offers, and trades in Cardiomatics's shares on secondary markets.